Evolution Group PLC
11 April 2001
The Evolution Group Plc ('the Company')
Further to the Company's circular dated 2 March 2001 and the passing of the
relevant resolutions at the EGM and 2.5p Warrantholders' Meeting held on 26
March 2001, the Company has today allotted 12,153,156 New Ordinary Shares to
holders of Adjusted 2.5p Warrants, 1p Warrants and Further Subscription Rights
who have now exercised their remaining Warrants and Further Subscription
Rights.
The exercise price per New Ordinary Shares was 2.5p per share in respect of
the Adjusted 2.5p Warrants, 1p per share in respect of the 1p Warrants, and an
average of 5.432p per share in respect of the FSRs (representing 27.16p in
aggregate per FSR).
Application was made on 2 March 2001 for such New Ordinary shares to be
admitted to AIM.
Accordingly dealings are expected to commence in the 12,153,156 New Ordinary
Shares with effect from the start of business on 12 April 2001.
Definitions set out in the Company's circular dated 2 March 2001 apply
throughout this announcement unless the context otherwise requires.
Further enquiries: Alex Snow - Chief executive 020 7444 1730
Adrian Graham - Finance director 020 7937 4445
11 April 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.